IMPAX LABORATORIES INC's ticker is and the CUSIP is 45256BAE1. A total of 6 filers reported holding IMPAX LABORATORIES INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $20,000 | 0.0% | 20,000 | 0.0% | 0.00% | – |
| Q4 2021 | $20,000 | 0.0% | 20,000 | 0.0% | 0.00% | – |
| Q3 2021 | $20,000 | 0.0% | 20,000 | 0.0% | 0.00% | – |
| Q2 2021 | $20,000 | 0.0% | 20,000 | 0.0% | 0.00% | – |
| Q1 2021 | $20,000 | 0.0% | 20,000 | 0.0% | 0.00% | – |
| Q4 2020 | $20,000 | 0.0% | 20,000 | 0.0% | 0.00% | – |
| Q3 2020 | $20,000 | 0.0% | 20,000 | 0.0% | 0.00% | – |
| Q2 2020 | $20,000 | +5.3% | 20,000 | 0.0% | 0.00% | – |
| Q1 2020 | $19,000 | 0.0% | 20,000 | 0.0% | 0.00% | – |
| Q4 2019 | $19,000 | 0.0% | 20,000 | 0.0% | 0.00% | – |
| Q3 2019 | $19,000 | -5.0% | 20,000 | 0.0% | 0.00% | – |
| Q2 2019 | $20,000 | 0.0% | 20,000 | 0.0% | 0.00% | – |
| Q1 2019 | $20,000 | 0.0% | 20,000 | 0.0% | 0.00% | – |
| Q4 2018 | $20,000 | 0.0% | 20,000 | 0.0% | 0.00% | – |
| Q3 2018 | $20,000 | 0.0% | 20,000 | 0.0% | 0.00% | – |
| Q2 2018 | $20,000 | 0.0% | 20,000 | 0.0% | 0.00% | – |
| Q1 2018 | $20,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 69,955 | $59,855,000 | 3.10% |
| Man Investments (CH) AG | 5,000,000 | $4,281,000 | 2.76% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 31,691,000 | $27,111,000 | 0.52% |
| GLG Partners LP | 7,750,000 | $6,636,000 | 0.37% |
| SSI INVESTMENT MANAGEMENT LLC | 3,000,000 | $2,552,000 | 0.22% |
| CAMDEN ASSET MANAGEMENT L P /CA | 8,596,000 | $7,312,000 | 0.22% |
| CANYON CAPITAL ADVISORS LLC | 15,000,000 | $12,759,000 | 0.21% |
| Verition Fund Management LLC | 2,000,000 | $1,711,000 | 0.17% |
| Lombard Odier Asset Management (Europe) Ltd | 3,360,000 | $2,876,000 | 0.16% |
| Allianz Asset Management GmbH | 72,475,000 | $61,966,000 | 0.06% |